Employees Retirement System of Texas’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY.RT
JCI
BC
TNB
WAM
IAIM
Employees Retirement System of Texas's BMY.RT Position: Q1 2021 in Review
Employees Retirement System of Texas sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 104,300 shares — an estimated $72K sold.
Employees Retirement System of Texas first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $396K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.
- Employees Retirement System of Texas reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
- Employees Retirement System of Texas sold 104,300 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $72K.
- Employees Retirement System of Texas first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
- Employees Retirement System of Texas's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $396K in Q1 2020.
- 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.
Based on Employees Retirement System of Texas's 13F filing for Q1 2021, filed 14 May 2021.